antibodies

Qué pasa si combino vacunas en la dosis de refuerzo

La FDA podría autorizar dosis de refuerzo de vacunas diferentes de los que los estadounidenses recibieron en sus primeras dosis. Hay evidencia científica prometedora que respalda la medida.

Qué pasa si combino vacunas en la dosis de refuerzo

La FDA podría autorizar dosis de refuerzo de vacunas diferentes de los que los estadounidenses recibieron en sus primeras dosis. Hay evidencia científica prometedora que respalda la medida.

Study of Covid Booster Shot Benefits Fans Debate Over Extra Doses

Independent experts, including government scientists, were skeptical of the research from Israel, which included limited data over a short period.

Study of Covid Booster Shot Benefits Fans Debate Over Extra Doses

Independent experts, including government scientists, were skeptical of the research from Israel, which included limited data over a short period.

Study of Booster Shot Benefits Fans Debate Over Extra Doses

Independent experts, including government scientists, were skeptical of the research from Israel, which included limited data over a short period.

As Virus Cases Surge, Biden Administration Encourages More Use of Antibody Treatments

A top White House adviser said monoclonal antibody treatments, sometimes underused, could still be crucial in helping people with Covid-19 avoid getting very sick.

As Virus Cases Surge, Biden Administration Encourages More Use of Antibody Treatments

A top White House adviser said monoclonal antibody treatments, sometimes underused, could still be crucial in helping people with Covid-19 avoid getting very sick.

UK study raises hopes of long COVID test within months

A diagnostic test to detect long COVID could be available within six to 12 months, following the discovery that patients with the chronic condition have distinctive antibodies in their blood.  Researchers at Imperial College London (ICL) led by Professor Danny Altmann told the BBC’s Panorama programme that they have identified a pattern of antibodies in …

UK study raises hopes of long COVID test within months Read More »

Una vacuna de bajo costo contra la COVID-19 está en marcha

Una nueva formulación que está entrando en ensayos clínicos en Brasil, México, Tailandia y Vietnam podría cambiar la forma en que el mundo combate la pandemia.

Una vacuna de bajo costo contra la COVID-19 está en marcha

Una nueva formulación que está entrando en ensayos clínicos en Brasil, México, Tailandia y Vietnam podría cambiar la forma en que el mundo combate la pandemia.

Researchers Are Hatching a Low-Cost Covid-19 Vaccine

A new formulation entering clinical trials in Brazil, Mexico, Thailand and Vietnam could change how the world fights the pandemic.

Researchers Are Hatching a Low-Cost Covid-19 Vaccine

A new formulation entering clinical trials in Brazil, Mexico, Thailand and Vietnam could change how the world fights the pandemic.

Researchers Are Hatching a Low-Cost Coronavirus Vaccine

A new formulation entering clinical trials in Brazil, Mexico, Thailand and Vietnam could change how the world fights the pandemic.

Gilead Expands its Collaboration with AbCellera to Develop Antibodies Against Multiple Indications

Shots: AbCellera to receive upfront, milestone, and royalties based on the development and commercialization of Abs, emerge under the collaboration The expanded collaboration will utilize AbCellera’s technology stack, which includes Trianni Mouse and OrthoMab protein engineering platform AbCellera will generate panels of Abs against up to 8 new targets across multiple indications, selected by Gilead …

Gilead Expands its Collaboration with AbCellera to Develop Antibodies Against Multiple Indications Read More »

ViewPoints Interview: Lumen’s Brian Finrow Shares Insight on Need for the Cheaper Methods to Engineer Antibodies as a Treatment for COVID-19

In an interview with PharmaShots, Brian Finrow, Co-Founder and CEO of Lumen Bioscience shared his views on the critical need for a scalable and cheaper method to engineer antibodies as a potential treatment for Covid-19. He also shed light on why it is time for the industry to reevaluate plant-based biologics manufacturing as a possible …

ViewPoints Interview: Lumen’s Brian Finrow Shares Insight on Need for the Cheaper Methods to Engineer Antibodies as a Treatment for COVID-19 Read More »

ViewPoints Interview: Adagio Therapeutics’ Tillman Gerngross Shares Insight on the Development of Antibodies to Prevent COVID-19

In an interview with PharmaShots, Tillman Gerngross, Ph.D., Co-Founder, and CEO of Adagio Therapeutics shed light on the pre-clinical data of ADG2 and how it works on SARS-CoV-2. Shots: ADG2 showed broad and potent neutralizing activity against SARS-CoV and two SARS-related coronaviruses currently known to be circulating in bat populations (WIV-1 and SHC014) The company …

ViewPoints Interview: Adagio Therapeutics’ Tillman Gerngross Shares Insight on the Development of Antibodies to Prevent COVID-19 Read More »

Why Covid Antibody Drugs Go Unused as Need Soars

While such treatments are promising, their use has been slowed by testing lags, overwhelmed hospitals and a perception the therapies are only for well-connected people.

Covid Antibody Drugs Go Unused as Need Soars

While such treatments are promising, their use has been slowed by testing lags, overwhelmed hospitals and a perception the therapies are only for well-connected people.

Why Covid Antibody Drugs Go Unused as Need Soars

While such treatments are promising, their use has been slowed by testing lags, overwhelmed hospitals and a perception the therapies are only for well-connected people.

Covid Meds Are Scarce, but Not for Trump Cronies

Rudy Giuliani got monoclonal antibodies. You probably can’t.

Covid Meds Are Scarce, but Not for Trump Cronies

Rudy Giuliani got monoclonal antibodies. You probably can’t.

Trump and Friends Got Coronavirus Care Many Others Couldn’t

Rudolph W. Giuliani became the latest in President Trump’s inner circle to boast about the treatment he received for Covid-19, as hospitals across the country ration care.

Model-based Strategy to Guide the Choice of Clinical Doses for ADC

Chemotherapy has been a powerful method for fighting cancer for decades. One of the most effective therapies available, it is also known for weakening the patient and causing harsh side effects like pain, nausea, and hair loss. This is because in its zeal to attack cancer cells, chemo also kills healthy cells. Enter antibody-drug conjugates …

Model-based Strategy to Guide the Choice of Clinical Doses for ADC Read More »

Qiagen to Launch Digital Test for Detecting SARS-CoV-2 Antibodies in the US

Shots: Qiagen reports the launch of the Access Anti-SARS-CoV-2 Total test that runs on a portable device and provides accurate results on Total Ig Abs (IgA, IgM, IgG) in 10mins. The device can process up to 8 samples simultaneously or up to 32 tests/hour The test was developed in collaboration with Ellume, following the US …

Qiagen to Launch Digital Test for Detecting SARS-CoV-2 Antibodies in the US Read More »